Phenotypic Resistance and the Dynamics of Bacterial Escape from Phage Control

The canonical view of phage - bacterial interactions in dense, liquid cultures is that the phage will eliminate most of the sensitive cells; genetic resistance will then ascend to restore high bacterial densities. Yet there are various mechanisms by which bacteria may remain sensitive to phages but still attain high densities in their presence – because bacteria enter a transient state of reduced adsorption. Importantly, these mechanisms may be cryptic and inapparent prior to the addition of phage yet result in a rapid rebound of bacterial density after phage are introduced. We describe mathematical models of these processes and suggest how different types of this ‘phenotypic’ resistance may be elucidated. We offer preliminary in vitro studies of a previously characterized E. coli model system and Campylobacter jejuni illustrating apparent phenotypic resistance. As phenotypic resistance may be specific to the receptors used by phages, awareness of its mechanisms may identify ways of improving the choice of phages for therapy. Phenotypic resistance can also explain several enigmas in the ecology of phage-bacterial dynamics. Phenotypic resistance does not preclude the evolution of genetic resistance and may often be an intermediate step to genetic resistance.

[1]  Rodolphe Barrangou,et al.  The Population and Evolutionary Dynamics of Phage and Bacteria with CRISPR–Mediated Immunity , 2013, PLoS genetics.

[2]  T. Lenormand,et al.  PHENOTYPIC STOCHASTICITY PROTECTS LYTIC BACTERIOPHAGE POPULATIONS FROM EXTINCTION DURING THE BACTERIAL STATIONARY PHASE , 2012, Evolution; international journal of organic evolution.

[3]  Bjarke Bak Christensen,et al.  Phase Variable Expression of Capsular Polysaccharide Modifications Allows Campylobacter jejuni to Avoid Bacteriophage Infection in Chickens , 2012, Front. Cell. Inf. Microbio..

[4]  David Bikard,et al.  Innate and adaptive immunity in bacteria: mechanisms of programmed genetic variation to fight bacteriophages. , 2012, Current opinion in immunology.

[5]  I. Molineux,et al.  In Vivo Growth Rates Are Poorly Correlated with Phage Therapy Success in a Mouse Infection Model , 2011, Antimicrobial Agents and Chemotherapy.

[6]  G. Volckaert,et al.  The T7-Related Pseudomonas putida Phage ϕ15 Displays Virion-Associated Biofilm Degradation Properties , 2011, PloS one.

[7]  B. Levin,et al.  An experimental study of the population and evolutionary dynamics of Vibrio cholerae O1 and the bacteriophage JSF4 , 2010, Proceedings of the Royal Society B: Biological Sciences.

[8]  J. Bull,et al.  A tale of tails: Sialidase is key to success in a model of phage therapy against K1-capsulated Escherichia coli. , 2010, Virology.

[9]  Carla J. Davidson,et al.  Individuality in bacteria. , 2008, Annual review of genetics.

[10]  O. Kuipers,et al.  Bistability, epigenetics, and bet-hedging in bacteria. , 2008, Annual review of microbiology.

[11]  J. Dushoff,et al.  Alternative stable states in host–phage dynamics , 2008, Theoretical Ecology.

[12]  B. Christensen,et al.  Characterization of Campylobacter phages including analysis of host range by selected Campylobacter Penner serotypes , 2007, BMC Microbiology.

[13]  J. Bull,et al.  Pharmacodynamics of non-replicating viruses, bacteriocins and lysins , 2006, Proceedings of the Royal Society B: Biological Sciences.

[14]  J. Bull,et al.  Optimality models of phage life history and parallels in disease evolution. , 2006, Journal of theoretical biology.

[15]  B. Levin,et al.  Non-inherited antibiotic resistance , 2006, Nature Reviews Microbiology.

[16]  S. Leibler,et al.  Bacterial Persistence as a Phenotypic Switch , 2004, Science.

[17]  J. Luzio,et al.  Prevention and Cure of Systemic Escherichia coli K1 Infection by Modification of the Bacterial Phenotype , 2004, Antimicrobial Agents and Chemotherapy.

[18]  J. Bull,et al.  Population and evolutionary dynamics of phage therapy , 2004, Nature Reviews Microbiology.

[19]  C. Bloch,et al.  Dynamics of success and failure in phage and antibiotic therapy in experimental infections , 2002, BMC Microbiology.

[20]  R. Lenski,et al.  Linking genetic change to community evolution: insights from studies of bacteria and bacteriophage , 2000 .

[21]  B. Barrell,et al.  The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences , 2000, Nature.

[22]  J. Mittler,et al.  Host-Parasite Coexistence: The Role of Spatial Refuges in Stabilizing Bacteria-Phage Interactions , 1996, The American Naturalist.

[23]  M. T. Horne,et al.  Co-adaptation of Escherichia coli and coliphage λvir in continuous culture , 1987 .

[24]  H. Smith,et al.  Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. , 1982, Journal of general microbiology.

[25]  F. M. Stewart,et al.  A Complex Community in a Simple Habitat: An Experimental Study with Bacteria and Phage , 1977 .

[26]  F. M. Stewart,et al.  Resource-Limited Growth, Competition, and Predation: A Model and Experimental Studies with Bacteria and Bacteriophage , 1977, The American Naturalist.

[27]  M. T. Horne,et al.  Autoxidation of Insect Lipids: Inhibition on the Cuticle of the American Cockroach , 1970, Science.

[28]  Allan Campbell,et al.  CONDITIONS FOR THE EXISTENCE OF BACTERIOPHAGE , 1961 .

[29]  L. Barksdale,et al.  Phenotypic alterations associated with the bacteriophage carrier state of Shigella dysenteriae. , 1961, Journal of general microbiology.

[30]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[31]  Jeffrey W. Smith,et al.  Stochastic Gene Expression in a Single Cell , 2022 .